Motavizumab

A4DAB172 | Infectious diseases | Phase-III
Respiratory Syncytial Virus Glycoprotein F
G1 / IgG1
MedImmune
Phase-III
Whole mAb
MEDI-524 MEDI 524 MEDI524 Numax Rezield
—
Avg A4D Score
-0.6921
Score Range
-0.72 to -0.66
Structures
15
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB172_4zyp_J_L 4zyp 100% -0.7082 6.5 4.0 -0.3514 -0.7517
A4DAB172_3qwo_A_B 3qwo 100% -0.706 6.5 9.0 -0.2103 -0.7654
A4DAB172_5k8a_B_A 5k8a 100% -0.7178 6.5 9.0 -0.353 -0.761
A4DAB172_5k8a_H_L 5k8a 100% -0.6913 6.5 9.0 -0.2097 -0.7482
A4DAB172_4jlr_H_L 4jlr 99% -0.6604 6.5 4.0 -0.1839 -0.7182
A4DAB172_6ywd_A_B 6ywd 100% -0.6717 6.5 9.0 -0.2355 -0.7232
A4DAB172_4zyp_N_O 4zyp 100% -0.6667 6.5 9.0 -0.251 -0.7173
A4DAB172_3ixt_A_B 3ixt 100% -0.7011 6.5 9.0 -0.2702 -0.7539
A4DAB172_3ixt_H_L 3ixt 100% -0.7026 6.5 9.0 -0.2422 -0.7587
A4DAB172_4zyp_K_M 4zyp 100% -0.6773 6.5 4.0 -0.2607 -0.7279
A4DAB172_4jlr_A_B 4jlr 99% -0.6827 6.5 4.0 -0.2608 -0.7339
A4DAB172_5k8a_F_E 5k8a 100% -0.7028 6.5 9.0 -0.2752 -0.7534
A4DAB172_5k8a_V_M 5k8a 100% -0.708 6.5 9.0 -0.2624 -0.7607
A4DAB172_3qwo_H_L 3qwo 100% -0.6755 6.5 9.0 -0.2571 -0.7256
A4DAB172_6oe5_B_C 6oe5 100% -0.7092 6.5 9.0 -0.3052 -0.7584